Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Dexamethasone 12 Bevacizumab 9 Saline Solution 8 Bupivacaine 8 Tobacco Use Cessation Devices 7 Specimen Handling 7 Nivolumab 7 Magnetic Resonance Spectroscopy 7 Rituximab 6 Prednisone 6 Letrozole 6 Lenalidomide 6 Fluorouracil 6 Cisplatin 6 Carboplatin 6 pembrolizumab 5 Sodium Chloride 5 Ropivacaine 5 Human Papillomavirus Recombinant Vaccine nonavalent 5 Trastuzumab 4 Tamoxifen 4 Standard of Care 4 Propofol 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4 Esomeprazole 4 Enoxaparin 4 Doxorubicin 4 Bortezomib 4 Bismuth 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × FluLaval × 1 year × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡